Syqe Medical Receives Regulatory Approval to Release World’s First Drug Delivery Device for Precise Dosing of Cannabis Leading pharma-tech company launches its first-in-class, pharmaceutical-grade cannabis inhaler in Israel; enabling...

The Canadian Cannabis Industry: Enter the Giants Guest Post by Michael Black, Director Consulting & Deals at PwC Canada The entrance of Constellation Brands in the cannabis industry has...

Israeli cannabis device maker Syqe Medical, which includes Philip Morris International as a major investor, has signed Teva Pharmaceuticals (NYSE: TEVA) to distribute its inhaler following its approval by...